based on past history, i smell a capital placement in the works. Granted we have a mgmt team and cfo that is on the ball vs old crew... expansion and associated cost is probably forthcoming..... and the preferred at 10.5% is probably a drain on earnings given 15 plus multiples on ebita valuations for biologic manuf...
Market Data 
Markets 
AI
